Amentoflavone suppresses tumor growth in ovarian cancer by modulating Skp2
- 1 November 2017
- journal article
- retracted article
- Published by Elsevier BV in Life Sciences
- Vol. 189, 96-105
- https://doi.org/10.1016/j.lfs.2017.09.026
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Emblica officinalis Extract Induces Autophagy and Inhibits Human Ovarian Cancer Cell Proliferation, Angiogenesis, Growth of Mouse Xenograft TumorsPLOS ONE, 2013
- Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2Cell Death & Disease, 2013
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and TumorigenesisCell, 2012
- The Biflavonoid Amentoflavone Induces Apoptosis via Suppressing E7 Expression, Cell Cycle Arrest at Sub-G1Phase, and Mitochondria-Emanated Intrinsic Pathways in Human Cervical Cancer CellsJournal of Medicinal Food, 2011
- Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancerLaboratory Investigation, 2009
- Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscinaBiochemical and Biophysical Research Communications, 2009
- Flavonoids and the Risk of Renal Cell CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2007
- Up-regulation of Skp2 after Prostate Cancer Cell Adhesion to Basement Membranes Results in BRCA2 Degradation and Cell ProliferationJournal of Biological Chemistry, 2006
- Overexpressed Skp2 within 5p amplification detected by array‐based comparative genomic hybridization is associated with poor prognosis of glioblastomasCancer Science, 2005
- Regulation of the cell cycle by SCF-type ubiquitin ligasesSeminars in Cell & Developmental Biology, 2005